Valion Bio Inc (VBIO) — Cash Flow-to-Debt Ratio
Valion Bio Inc (VBIO) has a Cash Flow-to-Debt Ratio of -0.15x as of December 2025, meaning its operating cash flow of $-2.29 Million could theoretically repay 0% of its total liabilities ($14.81 Million) in one year. See free cash flow generation of Valion Bio Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Valion Bio Inc Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Valion Bio Inc across 7 annual periods. Also explore VBIO net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Valion Bio Inc (2017–2025)
Year-by-year debt coverage analysis for Valion Bio Inc. For market capitalisation and broader financial context, see Valion Bio Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.47x | $-7.00 Million | $14.81 Million | ▲ +97.8% |
| 2024 | -21.05x | $-5.72 Million | $272.00K | ▼ -290.0% |
| 2023 | -5.40x | $-8.51 Million | $1.58 Million | ▼ -35.8% |
| 2022 | -3.97x | $-8.92 Million | $2.25 Million | ▲ +91.7% |
| 2020 | -48.00x | $-1.61 Million | $33.44K | ▼ -1617.6% |
| 2019 | -2.79x | $-3.59 Million | $1.28 Million | ▲ +65.8% |
| 2017 | -8.16x | $-2.89 Million | $353.52K | — |